The global contrast media agents market size was valued at USD 5.1 billion in 2021, It is excepted to reach USD 6.76 billion by 2028 at a CAGR of 4.1% during the forecast period 2022-2028 In medical imaging, contrast media or contrast agent is used to enhance the image of body parts produced by X-rays, magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound. These compounds are temporarily used to alter the interaction of imaging instruments or x-rays with the body. By enhancing the visibility of blood arteries, tissues, and specific organs, contrast medium or contrast agent aids clinicians in diagnosing medical disorders. Prior to an imaging scan, these compounds are injected into the body to help identify certain structures or tissues of interest from the surrounding tissue. Enema (rectally), orally, urethrally, or by injecting contrast media or contrast agent into the body are the four ways in which contrast media or contrast agent can be supplied into the body.

View Detailed Report Description at https://precisionbusinessinsights.com/market-reports/global-contrast-media-market/             

Owing to the technological developments in contrast agents, an increase in the installed base of CTs and MRIs, and an increase in the prevalence of chronic disease around the world, the global market is growing at a faster rate. A contrast agent/media is a material used in medical imaging to improve the contrast of body fluids and structures. X-ray, CT scan, angiography, as well as ultrasound imaging all use these chemicals. Iodine-based chemicals, barium sulfate-based compounds, and gadolinium-based compounds are the three main forms of contrast agents. Contrast media injectors are used to inject these substances through various routes of administration. The global contrast media market is booming, and it's predicted to keep growing at a stable CAGR from 2018 to 2026. During the forecast period, the global contrast media market is expected to grow due to an increase in the number of imaging devices such as CT and MRIs being installed, a rise in the prevalence of cancer and cardiovascular diseases, and an increase in awareness about pre-diagnosis of diseases like cancer and other cardiovascular diseases. Other factors predicted to boost the global market throughout the forecast period include increased awareness of sick diseases and increased health-care spending.

The global contrast media agents market segmentation:

1) by Product Type: Barium-based Contrast Media, Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media.

2) By Modality: X-Ray, CT-Scan, Magnetic Resonance Imaging (MRI), Ultrasound, Others.

3) By Route of Administration (Oral Contrast Media, Injectable Contrast Media, Rectal Contrast Media, Urethral Contrast Media, Others.

4) By Disease Indication: Musculoskeletal Disorders, Neurological Disorders, Nephrological Disorders, Cardiovascular Disorders, Oncology, Gastrointestinal Disorders.

5) By Application: Radiology, Interventional Radiology, Interventional Cardiology.

6) By End User: Hospitals, Clinics, Diagnostic Centers, Others.

Request sample report at  https://precisionbusinessinsights.com/request-sample/?product_id=30291                                                             

There are several industry players working in the Contrast Media Market, which include GE Healthcare (U.S.) Bayer AG (Germany) Guerbet Group (France) Daiichi Sankyo (Japan) Bracco Imaging S.p.A. (Italy) Medtronic plc. (Ireland) Spago Nanomedical AB (Sweden) nanoPet Pharma GmbH (Germany) Lantheus Medical Imaging Inc. (U.S.)

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:

Mr. Satya

Precision Business Insights| Toll Free: +1 866 598 1553

Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747